13. September 2017
We are proud to be a regular part of MSACL – this year in Salzburg from 10.- 14. September...Read more
1. September 2017
WELCOME! We are happy to announce that our new website is online. From now on you can find all...Read more
1. September 2017
September is Newborn Screening Awareness Month. Not only throughout this time we like to remind you, that you can...Read more
25. July 2017
An updated Consensus Guideline by worldwide experts is now available: See the publication of CLSI document NBS04-Ed2, Newborn Screening...Read more
10. July 2017
Background: Primary infection of Toxoplasma gondii during pregnancy can be transmitted to the unborn child and may have serious...Read more
5. July 2017
Background: Fabry disease (FD) is a rare X-linked lysosomal storage disease caused by mutations in the α-galactosidase A (GLA)...Read more
21. June 2017
We offer TREC (T-cell receptor excision circle) DNA testing from Dried Blood Spots to aid in screening newborns for...Read more
16. June 2017
Background: Fabry disease (FD), an X-linked lysosomal storage disorder, results from the deficient activity of α-galactosidase A (α-Gal A)...Read more
3. January 2017
Background: Fabry disease is an X-linked lysosomal storage disorder due to α-galactosidase A (α-Gal A) deficiency. Clinical onset of...Read more
19. October 2016
Background: Fabry disease (FD) is a rare X-linked lysosomal storage disorder due to mutations in the a-galactosidase A gene (GLA)...Read more
Started in 2013, ARCHIMEDlife is an independent highly-innovative company dedicated in providing and developing diagnostic services from Inborn Errors of Metabolism to Oncological Diseases. Our commitment is to provide better and faster high-quality laboratory tests for you and your family.
Our diagnostic laboratory is offering services from Clinical Mass Spectrometry to Next-Generation Sequencing. We have international collaborations with physicians, clinical researchers and industry specialized in personalized health care.
We are dedicated to the development of novel laboratory tests to make actionable health information accessible at the time it matters.